Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
By F. Bray, J. Ferlay, Isabelle Soerjomataram, R. Siegel, Lindsey A. Torre, A. Jemal. Ca, 2018
74,806 citations recorded by the source corpus.
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high‐quality cancer registry data, the basis for planning and implementing evidence‐based cancer control programs, are not available in most low‐ and middle‐income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1‐31. © 2018 American Cancer Society
Subfields: Economics and Econometrics, Oncology
View Paper: https://www.semanticscholar.org/paper/83ab5cf89399bca5449f4a7baf1b1b3c2e1178c7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- Gary S. Collins
- Karel G. M. Moons
- Prashanth Rawla
- J. Ferlay
- Andrew J. Vickers
- ZongYuan Ge
- Colin D Mathers
- Patrick M. M. Bossuyt
In Oncology
- J. Ferlay
- F. Bray
- Debesh Jha
- Pål Halvorsen
- Michael Alexander Riegler
- Dag Johansen
- Isabelle Soerjomataram
- Haavard D. Johansen
Citations in the corpus
- Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer (2020, background): “Introduction Although the combination of surgery, chemotherapy, targeted therapy, and immunotherapy has partially improved the clinical efficacy of colorectal cancer (CRC) therapy, CRC still ranks third in terms of incidence and is the second leading cause of cancerrelated deaths worldwide [1, 2].”
- A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis (2021, background): “Many research studies emphasize that this increase is also the result of environmental changes, such as a more sedentary lifestyle, abnormal bony weight (obesity), consumption of highly processed food, alcohol, red meat consumption and an increase in overall life expectancy [2,9,10].”
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge (2019, background): “Worldwide, breast cancer is the most commonly diagnosed type of cancer in women and the leading cause of cancer-related death [1].”
- METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma (2019, background): “Background Colorectal carcinoma (CRC) is a highly lethal cancer with an increasing incidence worldwide [1].”
- PAD-UFES-20: A skin lesion dataset composed of patient data and clinical images collected from smartphones (2020, background): “Most of the skin lesions are benign (non-cancerous) and do not offer a high risk; however, some instances of this disorder may evolve to skin cancer, the most common dysplasia around the world 2 .”
- Epidemiology of gastric cancer: global trends, risk factors and prevention (2018, background): “Although it is steadily declining in incidence, cancer of the stomach (also known as gastric cancer) remains one of the most common and deadly neoplasms in the world [1].”